Zobrazeno 1 - 10
of 191
pro vyhledávání: '"J. Säwe"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Different effects of inhibitors on the O - and N -demethylation of codeine in human liver microsomes
Publikováno v:
European Journal of Clinical Pharmacology. 52:41-47
Objective: The O- and N-demethylation of codeine is catalysed by CYP2D6 and CYP3A4 respectively. The formation rates of morphine by O-demethylation and norcodeine by N-demethylation were studied in two sets of human liver microsomes. Results: Relativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c4bf170e6b39f436249df7815019ae
https://doi.org/10.1007/s002280050247
https://doi.org/10.1007/s002280050247
Publikováno v:
Acta Anaesthesiologica Scandinavica. 40:177-186
Gastrointestinal side effects still constitute a major drawback in both acute and chronic use of opioids. The exact mechanism behind the gastrointestinal effects is not known, but experimental studies indicate both central and peripheral actions. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43e6b02376c2aa0706c1e92628a68b8
https://doi.org/10.1111/j.1399-6576.1996.tb04417.x
https://doi.org/10.1111/j.1399-6576.1996.tb04417.x
Autor:
E, Berntorp, J, Astermark, F, Baghaei, D, Bergqvist, M, Holmström, B, Ljungberg, A, Norlund, J, Palmblad, P, Petrini, L, Stigendal, J, Säwe
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(2)
In an ongoing health-technology assessment of haemophilia treatment in Sweden, performed by the governmental agency Dental and Pharmaceutical Benefits Agency (TLV; tandvårds-och lākemedelsförmånsverket), the Swedish Council on Health Technology A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b71984e02d0181198c2da75e8c9f8b9
https://pubmed.ncbi.nlm.nih.gov/22151198
https://pubmed.ncbi.nlm.nih.gov/22151198
Publikováno v:
European Journal of Clinical Pharmacology. 57:309-311
Objective: To study the prescribing of the antiobesity drug orlistat in relation to the approved indication and its weight-reducing effect in clinical practice during the first 3 months of treatment. Methods: Anonymous postal questionnaire survey to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e1cdf2ceedfd74c0c09444b5f771673
https://doi.org/10.1007/s002280100316
https://doi.org/10.1007/s002280100316
Autor:
Å, Ortqvist, M, Blennow, R-M, Carlsson, L Å, Hanson, A, Lindberg, L, Lindqvist, M, Magnusson, L, Nilsson, A, Norlund, O, Nyrén, P, Olcén, P, Olin, S-A, Silfverdal, J, Säwe, A, Söderström, B, Trollfors
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 99(461)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f19473ca45635211934689568d179ed
https://pubmed.ncbi.nlm.nih.gov/20712829
https://pubmed.ncbi.nlm.nih.gov/20712829
Publikováno v:
Transplant International. 5:S464-S469
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9a97f02f0891c40c2676bdfb141b25
https://doi.org/10.1111/tri.1992.5.s1.464
https://doi.org/10.1111/tri.1992.5.s1.464
Publikováno v:
European journal of clinical pharmacology. 57(4)
To study the prescribing of the antiobesity drug orlistat in relation to the approved indication and its weight-reducing effect in clinical practice during the first 3 months of treatment.Anonymous postal questionnaire survey to prescribers of orlist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5da81d7cead98baf133549b63e11edd
https://pubmed.ncbi.nlm.nih.gov/11549209
https://pubmed.ncbi.nlm.nih.gov/11549209
Publikováno v:
Clinical pharmacology and therapeutics. 69(1)
The pharmacokinetic interaction between sirolimus, a macrolide immunosuppressant metabolized by CYP3A4, and the calcium channel blocker diltiazem was studied in 18 healthy subjects. Several clinically important interactions have previously been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30b2dfb45fd225a3607cde58faa88ab8
https://pubmed.ncbi.nlm.nih.gov/11180036
https://pubmed.ncbi.nlm.nih.gov/11180036